Connection

Donald Castell to Gastroesophageal Reflux

This is a "connection" page, showing publications Donald Castell has written about Gastroesophageal Reflux.
Connection Strength

30.284
  1. Editorial: simultaneous prolonged monitoring of the acid pocket and oesophageal reflux. Aliment Pharmacol Ther. 2020 07; 52(2):397-398.
    View in: PubMed
    Score: 0.590
  2. Throat Clearing, Frequently Reported, But is it GERD Related? J Clin Gastroenterol. 2018 Nov/Dec; 52(10):869-872.
    View in: PubMed
    Score: 0.526
  3. Acid Control in Barrett's Esophagus: A Plea for Documentation. Am J Gastroenterol. 2018 02; 113(2):307.
    View in: PubMed
    Score: 0.499
  4. Symptom Index or Symptom Association Probability?: A Closer Look at Symptom Association in Suspected GERD Patients. J Clin Gastroenterol. 2018 Jan; 52(1):e7-e10.
    View in: PubMed
    Score: 0.496
  5. Symptom association latency during ambulatory reflux monitoring: a review of 1445 symptoms. Dis Esophagus. 2017 10 01; 30(10):1-6.
    View in: PubMed
    Score: 0.488
  6. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs. 2017 Apr; 77(5):547-561.
    View in: PubMed
    Score: 0.471
  7. Cough and Throat Clearing: Atypical GERD Symptoms or Not GERD at All? J Clin Gastroenterol. 2016 May-Jun; 50(5):e50-4.
    View in: PubMed
    Score: 0.442
  8. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression. Pharmacotherapy. 2015 Dec; 35(12):1124-9.
    View in: PubMed
    Score: 0.430
  9. A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial. J Clin Gastroenterol. 2015 Sep; 49(8):655-9.
    View in: PubMed
    Score: 0.422
  10. Monitoring for GE Reflux: Is Normal the New Normal? Dig Dis Sci. 2015 May; 60(5):1118-9.
    View in: PubMed
    Score: 0.412
  11. Swallowing activity assessed by ambulatory impedance-pH monitoring predicts awake and asleep periods at night. Dig Dis Sci. 2013 Apr; 58(4):1049-53.
    View in: PubMed
    Score: 0.348
  12. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing. Dis Esophagus. 2012 Nov-Dec; 25(8):682-6.
    View in: PubMed
    Score: 0.329
  13. Extraesophageal gastroesophageal reflux disease (GERD) symptoms are not more frequently associated with proximal esophageal reflux than typical GERD symptoms. Dis Esophagus. 2012 Nov-Dec; 25(8):678-81.
    View in: PubMed
    Score: 0.328
  14. Swallow evaluation during multichannel intraluminal impedance and pH: an alternate method to assess esophageal transit. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):862-6.
    View in: PubMed
    Score: 0.324
  15. Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 2010 Jun; 105(6):1266-75.
    View in: PubMed
    Score: 0.285
  16. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol. 2009 Oct; 43(9):816-20.
    View in: PubMed
    Score: 0.280
  17. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus. 2009; 22(5):467-70.
    View in: PubMed
    Score: 0.268
  18. Further comment on proton pump inhibitor failures. Clin Gastroenterol Hepatol. 2009 Mar; 7(3):363.
    View in: PubMed
    Score: 0.259
  19. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. J Clin Gastroenterol. 2008 Jul; 42(6):676-9.
    View in: PubMed
    Score: 0.257
  20. Reflux testing in the 21st century: is there a role for pH only? Clin Gastroenterol Hepatol. 2008 Aug; 6(8):840-1.
    View in: PubMed
    Score: 0.257
  21. Clinical importance of impedance measurements. J Clin Gastroenterol. 2008 May-Jun; 42(5):579-83.
    View in: PubMed
    Score: 0.254
  22. Characteristics of symptomatic reflux episodes on Acid suppressive therapy. Am J Gastroenterol. 2008 May; 103(5):1090-6.
    View in: PubMed
    Score: 0.254
  23. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring. Clin Gastroenterol Hepatol. 2008 May; 6(5):521-4.
    View in: PubMed
    Score: 0.252
  24. Is reflux dyspareunia a real entity? Nat Clin Pract Gastroenterol Hepatol. 2008 Apr; 5(4):192-3.
    View in: PubMed
    Score: 0.251
  25. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol. 2007 Feb; 5(2):172-7.
    View in: PubMed
    Score: 0.233
  26. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006 Dec; 93(12):1483-7.
    View in: PubMed
    Score: 0.230
  27. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther. 2006 Sep; 24 Suppl 2:27-37.
    View in: PubMed
    Score: 0.226
  28. The limitations of pH monitoring for detecting gastroesophageal reflux. Clin Gastroenterol Hepatol. 2006 Sep; 4(9):1184; author reply 1185.
    View in: PubMed
    Score: 0.226
  29. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest. 2006 Aug; 130(2):386-91.
    View in: PubMed
    Score: 0.225
  30. Comparison between the combined analysis and the DeMeester Score to predict response to PPI therapy. J Clin Gastroenterol. 2006 Aug; 40(7):602-5.
    View in: PubMed
    Score: 0.225
  31. Effects of a 5-HT(4) receptor agonist on oesophageal function and gastro-oesophageal reflux: studies using combined impedance-manometry and combined impedance-pH. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):155-62.
    View in: PubMed
    Score: 0.224
  32. GERD is chronic but not progressive. J Clin Gastroenterol. 2006 May-Jun; 40(5):374-5.
    View in: PubMed
    Score: 0.221
  33. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006 Oct; 55(10):1398-402.
    View in: PubMed
    Score: 0.219
  34. Esophageal pH monitoring: wireless does not mean worry less. J Clin Gastroenterol. 2006 Feb; 40(2):91-2.
    View in: PubMed
    Score: 0.217
  35. Laparoscopic Nissen fundoplication after biopolymer injection: a case report. Gastrointest Endosc. 2006 Mar; 63(3):520-2.
    View in: PubMed
    Score: 0.216
  36. Do we need to rethink fundoplication for patients who have failed proton-pump-inhibitor therapy? Nat Clin Pract Gastroenterol Hepatol. 2006 Jan; 3(1):2-3.
    View in: PubMed
    Score: 0.216
  37. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005 Nov; 6(14):2501-10.
    View in: PubMed
    Score: 0.214
  38. Ingestion of acidic foods mimics gastroesophageal reflux during pH monitoring. Dig Dis Sci. 2005 Oct; 50(10):1916-20.
    View in: PubMed
    Score: 0.212
  39. Nighttime reflux is primarily an early event. J Clin Gastroenterol. 2005 Aug; 39(7):579-83.
    View in: PubMed
    Score: 0.210
  40. Esophageal pH monitoring on PPI therapy: removing the blinders. Am J Gastroenterol. 2005 Aug; 100(8):1893-4; author reply 1894.
    View in: PubMed
    Score: 0.210
  41. The role of proximal pH monitoring. Am J Gastroenterol. 2005 Jul; 100(7):1621-2.
    View in: PubMed
    Score: 0.209
  42. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun 15; 21(12):1467-74.
    View in: PubMed
    Score: 0.208
  43. Fundoplication eliminates chronic cough due to non-acid reflux identified by impedance pH monitoring. Thorax. 2005 Jun; 60(6):521-3.
    View in: PubMed
    Score: 0.207
  44. Reflux monitoring: role of combined multichannel intraluminal impedance and pH. Gastrointest Endosc Clin N Am. 2005 Apr; 15(2):361-71.
    View in: PubMed
    Score: 0.205
  45. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005; 18(6):370-3.
    View in: PubMed
    Score: 0.202
  46. Non-acid gastroesophageal reflux: documenting its relationship to symptoms using multichannel intraluminal impedance (MII). Trans Am Clin Climatol Assoc. 2005; 116:321-33; discussion 333-4.
    View in: PubMed
    Score: 0.202
  47. Review article: the pathophysiology of gastro-oesophageal reflux disease - oesophageal manifestations. Aliment Pharmacol Ther. 2004 Dec; 20 Suppl 9:14-25.
    View in: PubMed
    Score: 0.200
  48. Nocturnal acid breakthrough - approach to management. MedGenMed. 2004 Oct 26; 6(4):11.
    View in: PubMed
    Score: 0.199
  49. Profile of GERD in the adult population of a northeast urban community. J Clin Gastroenterol. 2004 Sep; 38(8):651-7.
    View in: PubMed
    Score: 0.197
  50. The influence of rapid food intake on postprandial reflux: studies in healthy volunteers. Am J Gastroenterol. 2004 Sep; 99(9):1645-51.
    View in: PubMed
    Score: 0.197
  51. Diagnosis of laryngopharyngeal reflux. Curr Opin Otolaryngol Head Neck Surg. 2004 Jun; 12(3):174-9.
    View in: PubMed
    Score: 0.194
  52. Nocturnal acid breakthrough: pH, drugs and bugs. Eur J Gastroenterol Hepatol. 2004 May; 16(5):441-3.
    View in: PubMed
    Score: 0.192
  53. Rumination documented by using combined multichannel intraluminal impedance and manometry. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):340-3.
    View in: PubMed
    Score: 0.191
  54. Management of gastroesophageal reflux disease. Am J Med Sci. 2003 Nov; 326(5):309-18.
    View in: PubMed
    Score: 0.186
  55. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol. 2003 Sep; 37(3):206-15.
    View in: PubMed
    Score: 0.184
  56. Use of multichannel intraluminal impedance to document proximal esophageal and pharyngeal nonacidic reflux episodes. Am J Med. 2003 Aug 18; 115 Suppl 3A:119S-123S.
    View in: PubMed
    Score: 0.183
  57. Ambulatory intraesophageal pH monitoring: the reigning standard for reflux monitoring. J Clin Gastroenterol. 2003 Jul; 37(1):3-4.
    View in: PubMed
    Score: 0.182
  58. Nocturnal acid breakthrough in perspective: let's not throw out the baby with the bath water. Am J Gastroenterol. 2003 Mar; 98(3):517-8.
    View in: PubMed
    Score: 0.177
  59. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther. 2003 Jan; 17(2):243-51.
    View in: PubMed
    Score: 0.175
  60. Gastroesophageal reflux disease: natural history and long-term medical and surgical outcomes. Clin Cornerstone. 2003; 5(4):51-7; discussion 58-60.
    View in: PubMed
    Score: 0.175
  61. Noncardiac chest pain: on the horns of a dilemma. J Clin Gastroenterol. 2002 Jan; 34(1):3.
    View in: PubMed
    Score: 0.164
  62. Combined multichannel intraluminal impedance and pH-metry: an evolving technique to measure type and proximal extent of gastroesophageal reflux. Am J Med. 2001 Dec 03; 111 Suppl 8A:157S-159S.
    View in: PubMed
    Score: 0.163
  63. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther. 2001 Sep; 15(9):1351-6.
    View in: PubMed
    Score: 0.160
  64. Esophageal manometry prior to antireflux surgery: required, preferred, or even needed? Gastroenterology. 2001 Jul; 121(1):214-6.
    View in: PubMed
    Score: 0.158
  65. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001 Jun; 120(7):1599-606.
    View in: PubMed
    Score: 0.157
  66. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Aliment Pharmacol Ther. 2001 May; 15(5):647-52.
    View in: PubMed
    Score: 0.156
  67. Development of quality indicators for the diagnosis and management of achalasia. Neurogastroenterol Motil. 2021 10; 33(10):e14118.
    View in: PubMed
    Score: 0.155
  68. Aggressive acid control: minimizing progression of Barrett's esophagus. Am J Manag Care. 2001 Feb; 7(1 Suppl):S15-8.
    View in: PubMed
    Score: 0.154
  69. Medical therapy for gastroesophageal reflux disease. Mayo Clin Proc. 2001 Jan; 76(1):102-6.
    View in: PubMed
    Score: 0.153
  70. Effect of different recumbent positions on postprandial gastroesophageal reflux in normal subjects. Am J Gastroenterol. 2000 Oct; 95(10):2731-6.
    View in: PubMed
    Score: 0.150
  71. Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain. J Clin Gastroenterol. 2000 Sep; 31(2):121-4.
    View in: PubMed
    Score: 0.149
  72. Approach to the patient with unexplained chest pain. Am J Gastroenterol. 2000 Aug; 95(8 Suppl):S4-8.
    View in: PubMed
    Score: 0.148
  73. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000 Jun; 14(6):709-14.
    View in: PubMed
    Score: 0.147
  74. Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring. Curr Gastroenterol Rep. 2000 Jun; 2(3):173-4.
    View in: PubMed
    Score: 0.147
  75. Nasogastric tubes permit reflux and aspiration: is there any evidence? Ann Intern Med. 2000 Apr 04; 132(7):594-5.
    View in: PubMed
    Score: 0.145
  76. Medical therapy of supraesophageal gastroesophageal reflux disease. Am J Med. 2000 Mar 06; 108 Suppl 4a:170S-177S.
    View in: PubMed
    Score: 0.144
  77. Gastroesophageal reflux and abnormal esophageal pressures: cause or effect? J Clin Gastroenterol. 2000 Jan; 30(1):3.
    View in: PubMed
    Score: 0.143
  78. Medical therapy. Management of the refractory patient. Gastroenterol Clin North Am. 1999 Dec; 28(4):847-60.
    View in: PubMed
    Score: 0.142
  79. A practical approach to heartburn. Hosp Pract (1995). 1999 Nov 15; 34(12):89-94, 97-8.
    View in: PubMed
    Score: 0.141
  80. Oesophageal motility defects associated with nocturnal gastro-oesophageal reflux on proton pump inhibitors. Aliment Pharmacol Ther. 1999 Nov; 13(11):1467-71.
    View in: PubMed
    Score: 0.141
  81. Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. N Engl J Med. 2019 10 17; 381(16):1513-1523.
    View in: PubMed
    Score: 0.140
  82. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease. Am J Gastroenterol. 1999 Aug; 94(8):2069-73.
    View in: PubMed
    Score: 0.138
  83. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1999 Jun; 94(6):1434-42.
    View in: PubMed
    Score: 0.137
  84. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999 Jun; 94(6):1464-7.
    View in: PubMed
    Score: 0.137
  85. Cisapride 20 mg b.d. for preventing symptoms of GERD induced by a provocative meal. The CIS-USA-89 Study Group. Aliment Pharmacol Ther. 1999 Jun; 13(6):787-94.
    View in: PubMed
    Score: 0.137
  86. My approach to the difficult GERD patient. Eur J Gastroenterol Hepatol. 1999 Jun; 11 Suppl 1:S17-23.
    View in: PubMed
    Score: 0.137
  87. The hidden challenge of dyspepsia and heartburn: Is the world united? Summary and closing comments: key agenda for the coming years. Eur J Gastroenterol Hepatol. 1999 Jun; 11 Suppl 1:S43.
    View in: PubMed
    Score: 0.137
  88. Different effects of an oral anticholinergic drug on gastroesophageal reflux in upright and supine position in normal, ambulant subjects: a pilot study. Am J Gastroenterol. 1999 Apr; 94(4):925-30.
    View in: PubMed
    Score: 0.135
  89. Plasma levels of TNF-a, IL-6, IFN-?, IL-12, IL-17, IL-22, and IL-23 in achalasia, eosinophilic esophagitis (EoE), and gastroesophageal reflux disease (GERD). BMC Gastroenterol. 2019 Feb 11; 19(1):28.
    View in: PubMed
    Score: 0.134
  90. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors. Aliment Pharmacol Ther. 1998 Dec; 12(12):1231-4.
    View in: PubMed
    Score: 0.132
  91. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998 Dec; 12(12):1235-40.
    View in: PubMed
    Score: 0.132
  92. The acid suppression test for unexplained chest pain. Gastroenterology. 1998 Jul; 115(1):222-4.
    View in: PubMed
    Score: 0.128
  93. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci. 1998 Jul; 43(7):1513-7.
    View in: PubMed
    Score: 0.128
  94. Alternative therapies for GERD: a way to personalized antireflux surgery. Ann N Y Acad Sci. 2018 12; 1434(1):360-369.
    View in: PubMed
    Score: 0.127
  95. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998 May; 93(5):763-7.
    View in: PubMed
    Score: 0.127
  96. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018 07; 113(7):980-986.
    View in: PubMed
    Score: 0.127
  97. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group. Am J Gastroenterol. 1998 Apr; 93(4):547-52.
    View in: PubMed
    Score: 0.126
  98. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus. 1998 Apr; 11(2):106-8.
    View in: PubMed
    Score: 0.126
  99. Distal Esophageal Spasm: A Review. Am J Med. 2018 09; 131(9):1034-1040.
    View in: PubMed
    Score: 0.126
  100. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am. 1998 Mar; 27(1):153-67.
    View in: PubMed
    Score: 0.125
  101. Acid control and regression of Barrett's esophagus: is the glass half full or half empty? Am J Gastroenterol. 1997 Dec; 92(12):2329-30.
    View in: PubMed
    Score: 0.123
  102. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997 Oct; 42(10):2138-45.
    View in: PubMed
    Score: 0.122
  103. Gastroesophageal reflux disease in patients with columnar-lined esophagus. Gastroenterol Clin North Am. 1997 Sep; 26(3):549-63.
    View in: PubMed
    Score: 0.121
  104. Evaluation of the antireflux mechanism following laparoscopic fundoplication. Br J Surg. 1997 Aug; 84(8):1157-61.
    View in: PubMed
    Score: 0.121
  105. An objective assessment of laparoscopic antireflux surgery. Am J Surg. 1997 Jul; 174(1):63-7.
    View in: PubMed
    Score: 0.120
  106. Exclusion of the meal period improves the clinical reliability of esophageal pH monitoring. J Clin Gastroenterol. 1997 Jul; 25(1):314-6.
    View in: PubMed
    Score: 0.120
  107. Approach to the patient with unexplained chest pain. Compr Ther. 1997 Apr; 23(4):249-53.
    View in: PubMed
    Score: 0.118
  108. Lower esophageal sphincter or upper gastric sphincter? Dis Esophagus. 1997 Apr; 10(2):119-20.
    View in: PubMed
    Score: 0.118
  109. Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD). Semin Thorac Cardiovasc Surg. 1997 Apr; 9(2):169-72.
    View in: PubMed
    Score: 0.118
  110. The Role of Acid Suppression in Barrett's Esophagus. Am J Med. 2017 May; 130(5):525-529.
    View in: PubMed
    Score: 0.116
  111. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy. Am J Gastroenterol. 1996 Oct; 91(10):2110-3.
    View in: PubMed
    Score: 0.114
  112. Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. Am J Gastroenterol. 1996 Sep; 91(9):1715-8.
    View in: PubMed
    Score: 0.113
  113. Sensitization of esophageal mucosa by prior acid infusion: effect of decreasing intervals between infusions. Am J Gastroenterol. 1996 Sep; 91(9):1745-8.
    View in: PubMed
    Score: 0.113
  114. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol. 1996 Aug; 91(8):1527-31.
    View in: PubMed
    Score: 0.112
  115. A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1708-1714.e3.
    View in: PubMed
    Score: 0.112
  116. Obesity and gastro-oesophageal reflux: is there a relationship? Eur J Gastroenterol Hepatol. 1996 Jul; 8(7):625-6.
    View in: PubMed
    Score: 0.112
  117. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux. Am J Gastroenterol. 1996 Jun; 91(6):1162-6.
    View in: PubMed
    Score: 0.111
  118. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am J Gastroenterol. 1996 Jun; 91(6):1181-5.
    View in: PubMed
    Score: 0.111
  119. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. JAMA. 2016 May 17; 315(19):2104-12.
    View in: PubMed
    Score: 0.111
  120. Omeprazole works best when used properly. Eur J Gastroenterol Hepatol. 1996 May; 8(5):413-4.
    View in: PubMed
    Score: 0.111
  121. Excluding gastroesophageal reflux disease as the cause of chronic cough. J Clin Gastroenterol. 1996 Apr; 22(3):168-9.
    View in: PubMed
    Score: 0.110
  122. Gastroesophageal reflux disease. Current strategies for patient management. Arch Fam Med. 1996 Apr; 5(4):221-7.
    View in: PubMed
    Score: 0.110
  123. Ineffective Esophageal Motility (IEM): the Old-New Frontier in Esophagology. Curr Gastroenterol Rep. 2016 Jan; 18(1):1.
    View in: PubMed
    Score: 0.108
  124. Omeprazole for the treatment of posterior laryngitis. Am J Med. 1995 Dec; 99(6):694-5.
    View in: PubMed
    Score: 0.107
  125. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology. Arch Intern Med. 1995 Nov 13; 155(20):2165-73.
    View in: PubMed
    Score: 0.107
  126. Gastroesophageal reflux disease and asthma. Reflux or reflex? Chest. 1995 Nov; 108(5):1186-7.
    View in: PubMed
    Score: 0.107
  127. The effect of nasogastric intubation on gastroesophageal reflux: a comparison of different tube sizes. Am J Gastroenterol. 1995 Oct; 90(10):1804-7.
    View in: PubMed
    Score: 0.106
  128. The gold standard for assessing symptom associations. Gastroenterology. 1995 Jun; 108(6):1959-61.
    View in: PubMed
    Score: 0.104
  129. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual. Am J Gastroenterol. 1995 Feb; 90(2):280-4.
    View in: PubMed
    Score: 0.101
  130. Treatment of acid reflux. N Engl J Med. 1995 Jan 19; 332(3):190.
    View in: PubMed
    Score: 0.101
  131. Omeprazole failure in a patient with gastroesophageal reflux disease. Ann Intern Med. 1994 Dec 01; 121(11):899.
    View in: PubMed
    Score: 0.100
  132. Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring. Chest. 1994 Dec; 106(6):1793-6.
    View in: PubMed
    Score: 0.100
  133. Approach to the patient with unexplained chest pain. Mt Sinai J Med. 1994 Nov; 61(6):476-83.
    View in: PubMed
    Score: 0.100
  134. Current diagnosis and treatment of gastroesophageal reflux disease. Mayo Clin Proc. 1994 Sep; 69(9):867-76.
    View in: PubMed
    Score: 0.098
  135. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci. 1994 Aug; 39(8):1601-7.
    View in: PubMed
    Score: 0.098
  136. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus. Am J Gastroenterol. 1994 Jul; 89(7):989-91.
    View in: PubMed
    Score: 0.097
  137. Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med. 1994 Jul 01; 121(1):6-10.
    View in: PubMed
    Score: 0.097
  138. Body position affects recumbent postprandial reflux. J Clin Gastroenterol. 1994 Jun; 18(4):280-3.
    View in: PubMed
    Score: 0.097
  139. Long-term management of GERD: the pill, the knife, or the endoscope? Gastrointest Endosc. 1994 Mar-Apr; 40(2 Pt 1):252-3.
    View in: PubMed
    Score: 0.095
  140. A comparison of the effect of olestra and triglyceride on postprandial esophageal acid exposure. Am J Gastroenterol. 1993 Oct; 88(10):1734-7.
    View in: PubMed
    Score: 0.092
  141. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol. 1993 Jan; 88(1):25-9.
    View in: PubMed
    Score: 0.088
  142. Wireless 'mini' multichannel intraluminal impedance-pH: what is the optimal design of a miniature wireless device? Dis Esophagus. 2014 Jul; 27(5):424-7.
    View in: PubMed
    Score: 0.086
  143. Characterization of patients with low baseline impedance on multichannel intraluminal impedance-pH reflux testing. J Clin Gastroenterol. 2012 Aug; 46(7):e55-7.
    View in: PubMed
    Score: 0.085
  144. Prolonged intraesophageal pH monitoring with 16-hr overnight recording. Comparison with "24-hr" analysis. Dig Dis Sci. 1992 Jun; 37(6):857-64.
    View in: PubMed
    Score: 0.084
  145. Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid. Dig Dis Sci. 1992 Apr; 37(4):589-93.
    View in: PubMed
    Score: 0.083
  146. Impedance pH confirms the relationship between GERD and BMI. Dig Dis Sci. 2012 Jul; 57(7):1875-9.
    View in: PubMed
    Score: 0.083
  147. In the diagnosis of achalasia, "classic" might be "atypical". Clin Gastroenterol Hepatol. 2012 Jul; 10(7):821-2.
    View in: PubMed
    Score: 0.083
  148. Randomized, double-blind, placebo-controlled crossover trial of pirenzepine in patients with gastroesophageal reflux. Dig Dis Sci. 1992 Feb; 37(2):297-302.
    View in: PubMed
    Score: 0.082
  149. Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010. Aliment Pharmacol Ther. 2011 Apr; 33 Suppl 1:1-71.
    View in: PubMed
    Score: 0.078
  150. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med. 1991 Mar; 151(3):448-54.
    View in: PubMed
    Score: 0.077
  151. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1991; 5 Suppl 1:59-67.
    View in: PubMed
    Score: 0.076
  152. Use of endoscopic laser therapy to prevent reflux. Gastrointest Endosc. 1990 Sep-Oct; 36(5):531-2.
    View in: PubMed
    Score: 0.075
  153. Comparison of lower esophageal sphincter manometrics and gastroesophageal reflux measured by 24-hour pH recording. Am J Gastroenterol. 1990 Jun; 85(6):692-6.
    View in: PubMed
    Score: 0.073
  154. Gastroesophageal reflux in runners. Characteristics and treatment. Ann Intern Med. 1990 Mar 15; 112(6):429-33.
    View in: PubMed
    Score: 0.072
  155. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol. 1989 Dec; 84(12):1503-8.
    View in: PubMed
    Score: 0.071
  156. Asthma and gastroesophageal reflux. Chest. 1989 Jul; 96(1):2-3.
    View in: PubMed
    Score: 0.069
  157. Assessment of accuracy of intraesophageal pH probe in a dog model. Dig Dis Sci. 1989 Jul; 34(7):1079-84.
    View in: PubMed
    Score: 0.069
  158. Gastroesophageal reflux induced by exercise in healthy volunteers. JAMA. 1989 Jun 23-30; 261(24):3599-601.
    View in: PubMed
    Score: 0.068
  159. Does the intraesophageal pH probe accurately detect acid reflux? Simultaneous recording with two pH probes in humans. Dig Dis Sci. 1989 May; 34(5):649-56.
    View in: PubMed
    Score: 0.068
  160. Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol. 2009 May-Jun; 43(5):414-9.
    View in: PubMed
    Score: 0.068
  161. Chest pain of esophageal origin. Dig Dis. 1989; 7(1):39-50.
    View in: PubMed
    Score: 0.066
  162. Gastroesophageal reflux--the great imitator. West J Med. 1988 Jul; 149(1):81-2.
    View in: PubMed
    Score: 0.064
  163. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988 Apr; 83(4):358-61.
    View in: PubMed
    Score: 0.063
  164. Respiratory complications of gastroesophageal reflux. Am Fam Physician. 1988 Feb; 37(2):169-72.
    View in: PubMed
    Score: 0.062
  165. The changing paradigm of GERD. Curr Gastroenterol Rep. 2007 Dec; 9(6):441-2.
    View in: PubMed
    Score: 0.062
  166. Influence of bolus consistency and position on esophageal high-resolution manometry findings. Dig Dis Sci. 2008 May; 53(5):1198-205.
    View in: PubMed
    Score: 0.061
  167. Long-term therapy for chronic gastroesophageal reflux. Arch Intern Med. 1987 Oct; 147(10):1701-2.
    View in: PubMed
    Score: 0.061
  168. Effects of antireflux therapies on salivary function in normal humans. Dig Dis Sci. 1987 Jun; 32(6):603-8.
    View in: PubMed
    Score: 0.060
  169. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms. Aliment Pharmacol Ther. 2007 May 01; 25(9):1003-17.
    View in: PubMed
    Score: 0.059
  170. Review article: oesophageal spasm - diagnosis and management. Aliment Pharmacol Ther. 2006 May 15; 23(10):1393-402.
    View in: PubMed
    Score: 0.055
  171. Pressure details from the weight-challenged gastroesophageal junction: more than the usual suspects. Gastroenterology. 2006 Mar; 130(3):988-9.
    View in: PubMed
    Score: 0.055
  172. Ambulatory 24-hour esophageal pH monitoring. Technology searching for a clinical application. J Clin Gastroenterol. 1986; 8 Suppl 1:59-67.
    View in: PubMed
    Score: 0.054
  173. Respiratory complications of gastroesophageal reflux. Arch Intern Med. 1985 Oct; 145(10):1882-8.
    View in: PubMed
    Score: 0.053
  174. Are esophageal motility abnormalities produced during the intraesophageal acid perfusion test? JAMA. 1985 Apr 05; 253(13):1914-7.
    View in: PubMed
    Score: 0.051
  175. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005 Jan; 100(1):190-200.
    View in: PubMed
    Score: 0.050
  176. Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):399-406.
    View in: PubMed
    Score: 0.049
  177. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004 Jul; 53(7):1024-31.
    View in: PubMed
    Score: 0.049
  178. Combined multichannel intraluminal impedance and manometry clarifies esophageal function abnormalities: study in 350 patients. Am J Gastroenterol. 2004 Jun; 99(6):1011-9.
    View in: PubMed
    Score: 0.048
  179. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004 Jun; 99(6):1037-43.
    View in: PubMed
    Score: 0.048
  180. Angelchik anti-reflux device: radiographic appearance of complications. Radiology. 1984 May; 151(2):311-3.
    View in: PubMed
    Score: 0.048
  181. Complications of the Angelchik antireflux prosthesis. Ann Intern Med. 1984 Apr; 100(4):570-5.
    View in: PubMed
    Score: 0.048
  182. Histologic evaluation of chronic gastroesophageal reflux. An evaluation of biopsy methods and diagnostic criteria. Dig Dis Sci. 1984 Mar; 29(3):194-201.
    View in: PubMed
    Score: 0.048
  183. Gastroesophageal reflux. Compr Ther. 1983 Nov; 9(11):57-63.
    View in: PubMed
    Score: 0.046
  184. Barrett's esophagus prevalence and epidemiology. Gastrointest Endosc Clin N Am. 2003 Apr; 13(2):227-32.
    View in: PubMed
    Score: 0.045
  185. Laryngopharyngeal reflux identified using a new catheter design: defining normal values and excluding artifacts. Laryngoscope. 2003 Feb; 113(2):349-55.
    View in: PubMed
    Score: 0.044
  186. The Angelchik antireflux prosthesis. Effects on the lower esophageal sphincter of primates. Ann Surg. 1983 Jan; 197(1):63-7.
    View in: PubMed
    Score: 0.044
  187. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med. 1982 Jul; 97(1):93-103.
    View in: PubMed
    Score: 0.042
  188. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002 Feb; 55(2):149-56.
    View in: PubMed
    Score: 0.041
  189. Evaluation and management of diseases of the esophagus. Am J Otolaryngol. 1981 Nov; 2(4):336-44.
    View in: PubMed
    Score: 0.040
  190. In support of the clinical usefulness of lower esophageal sphincter pressure determination. Dig Dis Sci. 1981 Nov; 26(11):1028-31.
    View in: PubMed
    Score: 0.040
  191. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc. 2001 Apr; 53(4):407-15.
    View in: PubMed
    Score: 0.039
  192. Current approaches in the medical treatment of oesophageal reflux. Drugs. 1981 Apr; 21(4):283-91.
    View in: PubMed
    Score: 0.039
  193. The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2000 Nov; 14(11):1503-9.
    View in: PubMed
    Score: 0.038
  194. Total acid suppression and its effect on Barrett's esophagus. Am J Manag Care. 2000 Oct; 6(16 Suppl):S895-8.
    View in: PubMed
    Score: 0.038
  195. Pulmonary aspiration as a consequence of gastroesophageal reflux: a diagnostic approach. Dig Dis Sci. 1979 Nov; 24(11):839-44.
    View in: PubMed
    Score: 0.035
  196. Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers. Aliment Pharmacol Ther. 1999 Sep; 13(9):1211-4.
    View in: PubMed
    Score: 0.035
  197. Barrett's esophagus: continuing questions and controversy. Gastrointest Endosc. 1999 Mar; 49(3 Pt 2):S5-8.
    View in: PubMed
    Score: 0.034
  198. Normal patterns of acid exposure at the gastric cardia: a functional midpoint between the esophagus and stomach. Am J Gastroenterol. 1998 Aug; 93(8):1236-42.
    View in: PubMed
    Score: 0.032
  199. Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol. 1998 Jul; 93(7):1064-7.
    View in: PubMed
    Score: 0.032
  200. Esophageal manometry and modern medicine. Dig Dis. 1998 Jul-Aug; 16(4):189-91.
    View in: PubMed
    Score: 0.032
  201. Experimental study of acid burden and acute oesophagitis. Br J Surg. 1998 May; 85(5):677-80.
    View in: PubMed
    Score: 0.032
  202. Does sensitization of esophageal mucosal receptors occur during provocative testing? Am J Gastroenterol. 1997 Jun; 92(6):919-20.
    View in: PubMed
    Score: 0.030
  203. Asthma and gastroesophageal reflux. JAMA. 1977 May 30; 237(22):2379.
    View in: PubMed
    Score: 0.030
  204. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976 Nov; 21(11):953-6.
    View in: PubMed
    Score: 0.029
  205. Letter: Quantitation of gastroesophageal reflux. Gastroenterology. 1976 Jul; 71(1):179-80.
    View in: PubMed
    Score: 0.028
  206. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment, Suggested disease management guidelines. Arch Intern Med. 1996 Mar 11; 156(5):477-84.
    View in: PubMed
    Score: 0.027
  207. Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol. 1995 Oct; 90(10):1741-6.
    View in: PubMed
    Score: 0.027
  208. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases. Am J Gastroenterol. 1995 Oct; 90(10):1874-7.
    View in: PubMed
    Score: 0.027
  209. The lower esophageal sphincter. Physiologic and clinical aspects. Ann Intern Med. 1975 Sep; 83(3):390-401.
    View in: PubMed
    Score: 0.026
  210. Gastroesophageal reflux laryngitis resistant to omeprazole therapy. J Voice. 1995 Jun; 9(2):205-11.
    View in: PubMed
    Score: 0.026
  211. Omeprazole, serum gastrin, and gastric acid suppression. Ann Intern Med. 1995 Feb 01; 122(3):237-8.
    View in: PubMed
    Score: 0.025
  212. Chest pain of undetermined origin. Gastrointest Endosc Clin N Am. 1994 Oct; 4(4):731-46.
    View in: PubMed
    Score: 0.025
  213. Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol. 1993 Jun; 88(6):870-6.
    View in: PubMed
    Score: 0.023
  214. Esophageal disorders in the elderly. Gastroenterol Clin North Am. 1990 Jun; 19(2):235-54.
    View in: PubMed
    Score: 0.018
  215. Gastroesophageal reflux. Don't forget to ask about heartburn. Postgrad Med. 1989 Oct; 86(5):141-4, 147-8.
    View in: PubMed
    Score: 0.018
  216. Does sleeping on a waterbed promote gastroesophageal reflux? Dig Dis Sci. 1989 Oct; 34(10):1585-9.
    View in: PubMed
    Score: 0.018
  217. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989 Jul; 84(7):782-6.
    View in: PubMed
    Score: 0.017
  218. Acid perfusion test: does it have a role in the assessment of non cardiac chest pain? Gut. 1989 Mar; 30(3):305-10.
    View in: PubMed
    Score: 0.017
  219. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988 Sep; 33(9):1127-33.
    View in: PubMed
    Score: 0.016
  220. Esophageal motility disorders. Dis Mon. 1988 Jun; 34(6):297-389.
    View in: PubMed
    Score: 0.016
  221. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol. 1988 Jun; 83(6):633-6.
    View in: PubMed
    Score: 0.016
  222. Spontaneous noncardiac chest pain. Evaluation by 24-hour ambulatory esophageal motility and pH monitoring. Gastroenterology. 1988 Apr; 94(4):878-86.
    View in: PubMed
    Score: 0.016
  223. Chest pain associated with esophageal disease. Postgrad Med. 1988 Apr; 83(5):315-20.
    View in: PubMed
    Score: 0.016
  224. Esophageal disease as a cause of noncardiac chest pain. Adv Intern Med. 1988; 33:311-35.
    View in: PubMed
    Score: 0.016
  225. Evaluation of the Angelchik antireflux prosthesis using a model for esophageal reflux in rhesus monkeys. Ann Thorac Surg. 1986 Feb; 41(2):135-42.
    View in: PubMed
    Score: 0.014
  226. Esophageal motility disorders. Am J Med Sci. 1985 Aug; 290(2):61-9.
    View in: PubMed
    Score: 0.013
  227. Esophageal radionuclide transit tests. Potential false-positive results. Clin Nucl Med. 1984 Dec; 9(12):679-83.
    View in: PubMed
    Score: 0.013
  228. Clinical applications of oesophageal motility studies? Br J Hosp Med. 1984 Nov; 32(5):267-71.
    View in: PubMed
    Score: 0.012
  229. Oesophageal motility: recent advances and implications. Clin Sci (Lond). 1984 Aug; 67(2):145-51.
    View in: PubMed
    Score: 0.012
  230. Gastroesophageal reflux disease in the Zollinger-Ellison syndrome. Ann Intern Med. 1981 Jul; 95(1):37-43.
    View in: PubMed
    Score: 0.010
  231. Medical problems of the VIP. Mil Med. 1980 Jul; 145(7):476-9.
    View in: PubMed
    Score: 0.009
  232. Esophageal manometric studies: a perspective of their physiologic and clinical relevance. J Clin Gastroenterol. 1980 Jun; 2(2):191-6.
    View in: PubMed
    Score: 0.009
  233. Esophageal dysfunction in esophagopharyngeal regurgitation. Gastroenterology. 1980 May; 78(5 Pt 1):893-7.
    View in: PubMed
    Score: 0.009
  234. Esophageal mythology. JAMA. 1978 Jul 07; 240(1):44-6.
    View in: PubMed
    Score: 0.008
  235. Achalasia and diffuse esophageal spasm. Arch Intern Med. 1976 May; 136(5):571-9.
    View in: PubMed
    Score: 0.007
  236. Evaluation of the effect of fundoplication on the incompetent lower esophageal sphincter. Surg Gynecol Obstet. 1975 Oct; 141(4):571-5.
    View in: PubMed
    Score: 0.007
  237. Physiology and pathophysiology of the lower esophageal sphincter. Ann Otol Rhinol Laryngol. 1975 Sep-Oct; 84(5 Pt 1):569-75.
    View in: PubMed
    Score: 0.007
  238. The adverse effect of chocolate on lower esophageal sphincter pressure. Am J Dig Dis. 1975 Aug; 20(8):703-7.
    View in: PubMed
    Score: 0.007
  239. Cholinergic stimulation of the lower esophageal sphincter in patients with vagotomy and antrectomy. Am J Dig Dis. 1975 Mar; 20(3):195-200.
    View in: PubMed
    Score: 0.006
  240. Measurements and comparisons of lower esophageal sphincter pressures and serum gastrin levels in patients with gastroesophageal reflux. Gastroenterology. 1974 Sep; 67(3):415-22.
    View in: PubMed
    Score: 0.006
  241. Cholinergic therapy of chronic heartburn. A controlled trial. Ann Intern Med. 1974 May; 80(5):573-6.
    View in: PubMed
    Score: 0.006
  242. Stimulation of the incompetent lower esophageal sphincter. A possible advance in therapy of heartburn. Am J Dig Dis. 1973 Aug; 18(8):646-50.
    View in: PubMed
    Score: 0.006
  243. Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology. 1993 Jul; 105(1):31-9.
    View in: PubMed
    Score: 0.006
  244. Cholinergic response of the lower esophageal sphincter. Am J Physiol. 1972 Apr; 222(4):967-72.
    View in: PubMed
    Score: 0.005
  245. Dysphagia following fundoplication: "slipped" fundoplication versus achalasia complicated by fundoplication. Am J Gastroenterol. 1990 Nov; 85(11):1468-72.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.